141 related articles for article (PubMed ID: 31679973)
1. Design, synthesis and biological evaluation of novel desloratadine derivatives with anti-inflammatory and H
Li F; Xu Q; Zhu Q; Chu Z; Lin G; Mo J; Zhao Y; Li J; He G; Xu Y
Bioorg Med Chem Lett; 2019 Dec; 29(24):126712. PubMed ID: 31679973
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
[TBL] [Abstract][Full Text] [Related]
3. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases.
Chu Z; Cen L; Xu Q; Lin G; Mo J; Shao L; Zhao Y; Li J; Ye W; Fang T; Ren W; Zhu Q; He G; Xu Y
Eur J Med Chem; 2024 Mar; 268():116197. PubMed ID: 38368709
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
6. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
[TBL] [Abstract][Full Text] [Related]
7. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
Liu GZ; Xu HW; Chen GW; Wang P; Wang YN; Liu HM; Yu DQ
Bioorg Med Chem; 2010 Feb; 18(4):1626-32. PubMed ID: 20110173
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine.
Di Sciascio MB; Vianale G; Verna N; Petrarca C; Perrone A; Toniato E; Muraro R; Conti P; Di Gioacchino M
Int J Immunopathol Pharmacol; 2007; 20(4):745-51. PubMed ID: 18179747
[TBL] [Abstract][Full Text] [Related]
10. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
Gelfand EW; Appajosyula S; Meeves S
Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
13. Antihistamines: do they work? Further well-controlled trials involving larger samples are needed.
Fumagalli F; Baiardini I; Pasquali M; Compalati E; Guerra L; Massacane P; Canonica GW
Allergy; 2004 Aug; 59 Suppl 78():74-7. PubMed ID: 15245363
[TBL] [Abstract][Full Text] [Related]
14. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
15. [The place of new antihistamines in allergy management. Apropos of desloratadine].
Sabbah A
Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
[TBL] [Abstract][Full Text] [Related]
16. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
18. Route to Prolonged Residence Time at the Histamine H
Bosma R; Wang Z; Kooistra AJ; Bushby N; Kuhne S; van den Bor J; Waring MJ; de Graaf C; de Esch IJ; Vischer HF; Sheppard RJ; Wijtmans M; Leurs R
J Med Chem; 2019 Jul; 62(14):6630-6644. PubMed ID: 31274307
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic points of intervention and clinical implications: role of desloratadine.
Bachert C
Allergy; 2002; 57 Suppl 75():13-8. PubMed ID: 12492724
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine: A new, nonsedating, oral antihistamine.
Geha RS; Meltzer EO
J Allergy Clin Immunol; 2001 Apr; 107(4):751-62. PubMed ID: 11295678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
